Direkt zum Inhalt
Merck
  • Some sulfonamide drugs inhibit ATPase activity of heat shock protein 90: investigation by docking simulation and experimental validation.

Some sulfonamide drugs inhibit ATPase activity of heat shock protein 90: investigation by docking simulation and experimental validation.

Journal of enzyme inhibition and medicinal chemistry (2010-12-31)
Ghassan Abu Sheikha, Mahmoud A Al-Sha'er, Mutasem O Taha
ZUSAMMENFASSUNG

Eight selected sulfonamide drugs were investigated as inhibitors of heat shock protein 90 (Hsp90). The investigation included simulated docking experiments to fit the selected compounds within the binding pocket of Hsp90. The selected molecules were found to readily fit within the ATP-binding pocket of Hsp90 in low-energy poses. The sulfonamides torsemide, sulfathiazole, and sulfadiazine were found to inhibit the ATPase activity of Hsp90 with IC(50) values of 1.0, 2.6, and 1.5 μM, respectively. Our results suggest that these well-established sulfonamides can be good leads for subsequent optimization into potent Hsp90 inhibitors.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Sulfaguanidin
Preise und Verfügbarkeit sind derzeit nicht verfügbar.
Supelco
Sulfaguanidin, VETRANAL®, analytical standard
Preise und Verfügbarkeit sind derzeit nicht verfügbar.